Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
Published January 7, 2026 · Recall initiated: December 19, 2025
Summary
FDA records drug Class II recall D-0245-2026, published January 7, 2026 and initiated December 19, 2025. Recalling firm: Novo Nordisk Inc.; Status: Ongoing; Reported quantity: N/A; Lot: Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Hair was found in a prefilled syringe
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Novo Nordisk Inc.
- Distributor
- Nationwide within the United States.
- Lot
- Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAWegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo NordiskJanuary 7, 2026
- FDAOndansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets),January 7, 2026
- FDABD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG), 2% w/v and Isopropyl alcohol (IPA), 70% v/v),January 7, 2026
- FDAtraZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd.,January 7, 2026
- FDAALUMINIUM HAMMERED KADAI SIZE 7 8 901000 000057 MADE IN INDIAJanuary 7, 2026
- FDARestore Clinician Programmer Application (CP App), Model A71100 used with the following programmers: CT900ADecember 31, 2025
Questions about this recall
Was Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14 recalled?
Yes. FDA published recall D-0245-2026 on January 7, 2026. Reported hazard: Presence of Particulate Matter: Hair was found in a prefilled syringe
What should I do if I have this product?
Voluntary: Firm initiated · Letter